Health Sector Reels from Global Tech Outage and New Drug Approvals

The health sector faces challenges from a global IT outage impacting hospitals in Germany, England, and Canada. Eli Lilly's tirzepatide receives approval in China, while Boehringer Ingelheim partners with GoodRx for a discounted Humira rival. The US CDC identifies new bird flu cases in Colorado, and Abbott plans a marketing push for glucose monitors.

Health news this week highlights a global IT outage affecting hospitals in Germany, England, and Canada, causing disruptions in elective surgeries and appointment bookings while sparing emergency services. The incident is linked to a cybersecurity firm, Crowdstrike.

In pharmaceutical news, Eli Lilly's weight loss drug tirzepatide has been approved by Chinese regulators, increasing competition with Novo Nordisk. Concurrently, Boehringer Ingelheim and GoodRx are offering a Humira alternative at a significant discount.

Additionally, the US CDC confirms new bird flu cases in Colorado, amplifying concerns in the poultry sector. Abbott Laboratories is planning an ambitious marketing push for its new glucose monitoring device, Lingo, targeting beyond diabetic patients.

(With inputs from agencies.)